nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Gefitinib—lung cancer	0.0664	0.125	CbGbCtD
Oxymorphone—CYP2D6—Vinorelbine—lung cancer	0.0511	0.096	CbGbCtD
Oxymorphone—CYP3A4—Topotecan—lung cancer	0.0462	0.0867	CbGbCtD
Oxymorphone—CYP3A4—Gefitinib—lung cancer	0.0422	0.0793	CbGbCtD
Oxymorphone—CYP3A4—Teniposide—lung cancer	0.0409	0.0769	CbGbCtD
Oxymorphone—CYP2D6—Erlotinib—lung cancer	0.0393	0.0737	CbGbCtD
Oxymorphone—CYP3A4—Vinorelbine—lung cancer	0.0325	0.0611	CbGbCtD
Oxymorphone—CYP2D6—Vinblastine—lung cancer	0.0315	0.0592	CbGbCtD
Oxymorphone—CYP3A4—Crizotinib—lung cancer	0.0259	0.0486	CbGbCtD
Oxymorphone—CYP3A4—Erlotinib—lung cancer	0.025	0.0469	CbGbCtD
Oxymorphone—CYP3A4—Paclitaxel—lung cancer	0.0229	0.0429	CbGbCtD
Oxymorphone—CYP3A4—Irinotecan—lung cancer	0.0225	0.0423	CbGbCtD
Oxymorphone—CYP3A4—Vinblastine—lung cancer	0.02	0.0376	CbGbCtD
Oxymorphone—CYP2D6—Doxorubicin—lung cancer	0.0194	0.0364	CbGbCtD
Oxymorphone—CYP3A4—Etoposide—lung cancer	0.0181	0.0339	CbGbCtD
Oxymorphone—CYP3A4—Docetaxel—lung cancer	0.0165	0.031	CbGbCtD
Oxymorphone—CYP3A4—Doxorubicin—lung cancer	0.0123	0.0231	CbGbCtD
Oxymorphone—Naltrexone—UGT1A1—lung cancer	0.00226	0.295	CrCbGaD
Oxymorphone—Morphine—UGT1A1—lung cancer	0.00139	0.182	CrCbGaD
Oxymorphone—Buprenorphine—CYP2A6—lung cancer	0.00104	0.136	CrCbGaD
Oxymorphone—Buprenorphine—ABCG2—lung cancer	0.000935	0.122	CrCbGaD
Oxymorphone—Naltrexone—ABCB1—lung cancer	0.000529	0.069	CrCbGaD
Oxymorphone—Naloxone—ALB—lung cancer	0.000405	0.0528	CrCbGaD
Oxymorphone—Buprenorphine—ABCB1—lung cancer	0.000389	0.0507	CrCbGaD
Oxymorphone—Naloxone—ABCB1—lung cancer	0.000386	0.0503	CrCbGaD
Oxymorphone—Morphine—ABCB1—lung cancer	0.000326	0.0425	CrCbGaD
Oxymorphone—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000285	0.000781	CcSEcCtD
Oxymorphone—Fatigue—Gemcitabine—lung cancer	0.000285	0.00078	CcSEcCtD
Oxymorphone—Confusional state—Etoposide—lung cancer	0.000284	0.000779	CcSEcCtD
Oxymorphone—Pain—Gemcitabine—lung cancer	0.000282	0.000774	CcSEcCtD
Oxymorphone—Constipation—Gemcitabine—lung cancer	0.000282	0.000774	CcSEcCtD
Oxymorphone—Nausea—Erlotinib—lung cancer	0.000282	0.000774	CcSEcCtD
Oxymorphone—Dry mouth—Paclitaxel—lung cancer	0.000282	0.000773	CcSEcCtD
Oxymorphone—Diarrhoea—Vinorelbine—lung cancer	0.000281	0.00077	CcSEcCtD
Oxymorphone—Feeling abnormal—Irinotecan—lung cancer	0.000279	0.000765	CcSEcCtD
Oxymorphone—Confusional state—Paclitaxel—lung cancer	0.000279	0.000764	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Irinotecan—lung cancer	0.000277	0.000759	CcSEcCtD
Oxymorphone—Dehydration—Doxorubicin—lung cancer	0.000277	0.000758	CcSEcCtD
Oxymorphone—Oedema—Paclitaxel—lung cancer	0.000276	0.000757	CcSEcCtD
Oxymorphone—Tachycardia—Etoposide—lung cancer	0.000275	0.000754	CcSEcCtD
Oxymorphone—Dyspnoea—Cisplatin—lung cancer	0.000274	0.000752	CcSEcCtD
Oxymorphone—Skin disorder—Etoposide—lung cancer	0.000274	0.00075	CcSEcCtD
Oxymorphone—Hyperhidrosis—Etoposide—lung cancer	0.000272	0.000747	CcSEcCtD
Oxymorphone—Feeling abnormal—Gemcitabine—lung cancer	0.000272	0.000746	CcSEcCtD
Oxymorphone—Shock—Paclitaxel—lung cancer	0.000272	0.000745	CcSEcCtD
Oxymorphone—Dizziness—Vinorelbine—lung cancer	0.000272	0.000745	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Doxorubicin—lung cancer	0.000272	0.000745	CcSEcCtD
Oxymorphone—Nervous system disorder—Paclitaxel—lung cancer	0.000271	0.000743	CcSEcCtD
Oxymorphone—Tachycardia—Paclitaxel—lung cancer	0.00027	0.000739	CcSEcCtD
Oxymorphone—Anorexia—Etoposide—lung cancer	0.000269	0.000736	CcSEcCtD
Oxymorphone—Skin disorder—Paclitaxel—lung cancer	0.000268	0.000736	CcSEcCtD
Oxymorphone—Abdominal pain—Irinotecan—lung cancer	0.000268	0.000734	CcSEcCtD
Oxymorphone—Body temperature increased—Irinotecan—lung cancer	0.000268	0.000734	CcSEcCtD
Oxymorphone—Decreased appetite—Cisplatin—lung cancer	0.000267	0.000733	CcSEcCtD
Oxymorphone—Hyperhidrosis—Paclitaxel—lung cancer	0.000267	0.000732	CcSEcCtD
Oxymorphone—Pneumonia—Methotrexate—lung cancer	0.000266	0.00073	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Cisplatin—lung cancer	0.000266	0.000728	CcSEcCtD
Oxymorphone—Anorexia—Paclitaxel—lung cancer	0.000263	0.000722	CcSEcCtD
Oxymorphone—Hypotension—Etoposide—lung cancer	0.000263	0.000722	CcSEcCtD
Oxymorphone—Pain—Cisplatin—lung cancer	0.000263	0.000721	CcSEcCtD
Oxymorphone—Vomiting—Vinorelbine—lung cancer	0.000261	0.000716	CcSEcCtD
Oxymorphone—Body temperature increased—Gemcitabine—lung cancer	0.000261	0.000715	CcSEcCtD
Oxymorphone—Dermatitis—Vinorelbine—lung cancer	0.000259	0.000709	CcSEcCtD
Oxymorphone—Abdominal distension—Doxorubicin—lung cancer	0.000259	0.000709	CcSEcCtD
Oxymorphone—Hypotension—Paclitaxel—lung cancer	0.000258	0.000708	CcSEcCtD
Oxymorphone—Headache—Vinorelbine—lung cancer	0.000257	0.000705	CcSEcCtD
Oxymorphone—Syncope—Docetaxel—lung cancer	0.000257	0.000705	CcSEcCtD
Oxymorphone—Palpitations—Docetaxel—lung cancer	0.000254	0.000695	CcSEcCtD
Oxymorphone—Feeling abnormal—Cisplatin—lung cancer	0.000253	0.000695	CcSEcCtD
Oxymorphone—Loss of consciousness—Docetaxel—lung cancer	0.000252	0.000691	CcSEcCtD
Oxymorphone—Dyspnoea—Etoposide—lung cancer	0.000251	0.000689	CcSEcCtD
Oxymorphone—Somnolence—Etoposide—lung cancer	0.000251	0.000687	CcSEcCtD
Oxymorphone—Insomnia—Paclitaxel—lung cancer	0.00025	0.000685	CcSEcCtD
Oxymorphone—Hypersensitivity—Irinotecan—lung cancer	0.00025	0.000684	CcSEcCtD
Oxymorphone—Convulsion—Docetaxel—lung cancer	0.000249	0.000682	CcSEcCtD
Oxymorphone—Hypertension—Docetaxel—lung cancer	0.000248	0.000679	CcSEcCtD
Oxymorphone—Dyspnoea—Paclitaxel—lung cancer	0.000246	0.000675	CcSEcCtD
Oxymorphone—Somnolence—Paclitaxel—lung cancer	0.000246	0.000673	CcSEcCtD
Oxymorphone—Decreased appetite—Etoposide—lung cancer	0.000245	0.000672	CcSEcCtD
Oxymorphone—Chest pain—Docetaxel—lung cancer	0.000244	0.00067	CcSEcCtD
Oxymorphone—Nausea—Vinorelbine—lung cancer	0.000244	0.000669	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Etoposide—lung cancer	0.000243	0.000667	CcSEcCtD
Oxymorphone—Dyspepsia—Paclitaxel—lung cancer	0.000243	0.000667	CcSEcCtD
Oxymorphone—Body temperature increased—Cisplatin—lung cancer	0.000243	0.000667	CcSEcCtD
Oxymorphone—Asthenia—Irinotecan—lung cancer	0.000243	0.000666	CcSEcCtD
Oxymorphone—Fatigue—Etoposide—lung cancer	0.000243	0.000666	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000243	0.000665	CcSEcCtD
Oxymorphone—Pain—Etoposide—lung cancer	0.000241	0.000661	CcSEcCtD
Oxymorphone—Constipation—Etoposide—lung cancer	0.000241	0.000661	CcSEcCtD
Oxymorphone—Decreased appetite—Paclitaxel—lung cancer	0.00024	0.000658	CcSEcCtD
Oxymorphone—Dry mouth—Docetaxel—lung cancer	0.000239	0.000655	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000239	0.000654	CcSEcCtD
Oxymorphone—Fatigue—Paclitaxel—lung cancer	0.000238	0.000653	CcSEcCtD
Oxymorphone—Asthenia—Gemcitabine—lung cancer	0.000237	0.000649	CcSEcCtD
Oxymorphone—Pain—Paclitaxel—lung cancer	0.000236	0.000648	CcSEcCtD
Oxymorphone—Constipation—Paclitaxel—lung cancer	0.000236	0.000648	CcSEcCtD
Oxymorphone—Confusional state—Docetaxel—lung cancer	0.000236	0.000647	CcSEcCtD
Oxymorphone—Urinary tract disorder—Methotrexate—lung cancer	0.000235	0.000643	CcSEcCtD
Oxymorphone—Oedema—Docetaxel—lung cancer	0.000234	0.000642	CcSEcCtD
Oxymorphone—Pruritus—Gemcitabine—lung cancer	0.000233	0.00064	CcSEcCtD
Oxymorphone—Urethral disorder—Methotrexate—lung cancer	0.000233	0.000638	CcSEcCtD
Oxymorphone—Weight decreased—Doxorubicin—lung cancer	0.000233	0.000637	CcSEcCtD
Oxymorphone—Feeling abnormal—Etoposide—lung cancer	0.000232	0.000637	CcSEcCtD
Oxymorphone—Diarrhoea—Irinotecan—lung cancer	0.000232	0.000635	CcSEcCtD
Oxymorphone—Pneumonia—Doxorubicin—lung cancer	0.00023	0.000632	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Etoposide—lung cancer	0.00023	0.000632	CcSEcCtD
Oxymorphone—Shock—Docetaxel—lung cancer	0.00023	0.000632	CcSEcCtD
Oxymorphone—Nervous system disorder—Docetaxel—lung cancer	0.00023	0.00063	CcSEcCtD
Oxymorphone—Visual impairment—Methotrexate—lung cancer	0.000229	0.000628	CcSEcCtD
Oxymorphone—Tachycardia—Docetaxel—lung cancer	0.000229	0.000627	CcSEcCtD
Oxymorphone—Feeling abnormal—Paclitaxel—lung cancer	0.000228	0.000624	CcSEcCtD
Oxymorphone—Skin disorder—Docetaxel—lung cancer	0.000227	0.000624	CcSEcCtD
Oxymorphone—Hypersensitivity—Cisplatin—lung cancer	0.000227	0.000621	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000226	0.000619	CcSEcCtD
Oxymorphone—Diarrhoea—Gemcitabine—lung cancer	0.000226	0.000619	CcSEcCtD
Oxymorphone—Dizziness—Irinotecan—lung cancer	0.000224	0.000614	CcSEcCtD
Oxymorphone—Urticaria—Etoposide—lung cancer	0.000224	0.000614	CcSEcCtD
Oxymorphone—Anorexia—Docetaxel—lung cancer	0.000223	0.000612	CcSEcCtD
Oxymorphone—Abdominal pain—Etoposide—lung cancer	0.000223	0.000611	CcSEcCtD
Oxymorphone—Body temperature increased—Etoposide—lung cancer	0.000223	0.000611	CcSEcCtD
Oxymorphone—Eye disorder—Methotrexate—lung cancer	0.000222	0.000609	CcSEcCtD
Oxymorphone—Asthenia—Cisplatin—lung cancer	0.000221	0.000605	CcSEcCtD
Oxymorphone—Cardiac disorder—Methotrexate—lung cancer	0.00022	0.000604	CcSEcCtD
Oxymorphone—Urticaria—Paclitaxel—lung cancer	0.000219	0.000602	CcSEcCtD
Oxymorphone—Hypotension—Docetaxel—lung cancer	0.000219	0.0006	CcSEcCtD
Oxymorphone—Abdominal pain—Paclitaxel—lung cancer	0.000218	0.000599	CcSEcCtD
Oxymorphone—Body temperature increased—Paclitaxel—lung cancer	0.000218	0.000599	CcSEcCtD
Oxymorphone—Angiopathy—Methotrexate—lung cancer	0.000216	0.000591	CcSEcCtD
Oxymorphone—Vomiting—Irinotecan—lung cancer	0.000215	0.000591	CcSEcCtD
Oxymorphone—Immune system disorder—Methotrexate—lung cancer	0.000215	0.000588	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methotrexate—lung cancer	0.000214	0.000587	CcSEcCtD
Oxymorphone—Dermatitis—Irinotecan—lung cancer	0.000213	0.000585	CcSEcCtD
Oxymorphone—Headache—Irinotecan—lung cancer	0.000212	0.000582	CcSEcCtD
Oxymorphone—Insomnia—Docetaxel—lung cancer	0.000212	0.000581	CcSEcCtD
Oxymorphone—Diarrhoea—Cisplatin—lung cancer	0.00021	0.000577	CcSEcCtD
Oxymorphone—Vomiting—Gemcitabine—lung cancer	0.00021	0.000575	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—lung cancer	0.000209	0.000574	CcSEcCtD
Oxymorphone—Dyspnoea—Docetaxel—lung cancer	0.000209	0.000572	CcSEcCtD
Oxymorphone—Somnolence—Docetaxel—lung cancer	0.000208	0.000571	CcSEcCtD
Oxymorphone—Mental disorder—Methotrexate—lung cancer	0.000208	0.000571	CcSEcCtD
Oxymorphone—Dermatitis—Gemcitabine—lung cancer	0.000208	0.00057	CcSEcCtD
Oxymorphone—Hypersensitivity—Etoposide—lung cancer	0.000208	0.000569	CcSEcCtD
Oxymorphone—Malnutrition—Methotrexate—lung cancer	0.000207	0.000567	CcSEcCtD
Oxymorphone—Headache—Gemcitabine—lung cancer	0.000207	0.000567	CcSEcCtD
Oxymorphone—Dyspepsia—Docetaxel—lung cancer	0.000206	0.000565	CcSEcCtD
Oxymorphone—Decreased appetite—Docetaxel—lung cancer	0.000204	0.000558	CcSEcCtD
Oxymorphone—Hypersensitivity—Paclitaxel—lung cancer	0.000204	0.000558	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—lung cancer	0.000203	0.000557	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Docetaxel—lung cancer	0.000202	0.000554	CcSEcCtD
Oxymorphone—Asthenia—Etoposide—lung cancer	0.000202	0.000554	CcSEcCtD
Oxymorphone—Fatigue—Docetaxel—lung cancer	0.000202	0.000554	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—lung cancer	0.000202	0.000553	CcSEcCtD
Oxymorphone—Nausea—Irinotecan—lung cancer	0.000201	0.000552	CcSEcCtD
Oxymorphone—Constipation—Docetaxel—lung cancer	0.0002	0.000549	CcSEcCtD
Oxymorphone—Pain—Docetaxel—lung cancer	0.0002	0.000549	CcSEcCtD
Oxymorphone—Pruritus—Etoposide—lung cancer	0.000199	0.000547	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—lung cancer	0.000198	0.000543	CcSEcCtD
Oxymorphone—Asthenia—Paclitaxel—lung cancer	0.000198	0.000543	CcSEcCtD
Oxymorphone—Nausea—Gemcitabine—lung cancer	0.000196	0.000537	CcSEcCtD
Oxymorphone—Vomiting—Cisplatin—lung cancer	0.000196	0.000536	CcSEcCtD
Oxymorphone—Pruritus—Paclitaxel—lung cancer	0.000195	0.000536	CcSEcCtD
Oxymorphone—Vision blurred—Methotrexate—lung cancer	0.000195	0.000534	CcSEcCtD
Oxymorphone—Dermatitis—Cisplatin—lung cancer	0.000194	0.000531	CcSEcCtD
Oxymorphone—Feeling abnormal—Docetaxel—lung cancer	0.000193	0.000529	CcSEcCtD
Oxymorphone—Diarrhoea—Etoposide—lung cancer	0.000193	0.000529	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—lung cancer	0.000192	0.000527	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Docetaxel—lung cancer	0.000192	0.000525	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—lung cancer	0.000191	0.000523	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—lung cancer	0.000191	0.000523	CcSEcCtD
Oxymorphone—Diarrhoea—Paclitaxel—lung cancer	0.000189	0.000518	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—lung cancer	0.000187	0.000512	CcSEcCtD
Oxymorphone—Dizziness—Etoposide—lung cancer	0.000186	0.000511	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—lung cancer	0.000186	0.000509	CcSEcCtD
Oxymorphone—Vertigo—Methotrexate—lung cancer	0.000186	0.000509	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—lung cancer	0.000185	0.000508	CcSEcCtD
Oxymorphone—Abdominal pain—Docetaxel—lung cancer	0.000185	0.000508	CcSEcCtD
Oxymorphone—Body temperature increased—Docetaxel—lung cancer	0.000185	0.000508	CcSEcCtD
Oxymorphone—Dizziness—Paclitaxel—lung cancer	0.000183	0.000501	CcSEcCtD
Oxymorphone—Nausea—Cisplatin—lung cancer	0.000183	0.000501	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—lung cancer	0.00018	0.000494	CcSEcCtD
Oxymorphone—Convulsion—Methotrexate—lung cancer	0.000179	0.000491	CcSEcCtD
Oxymorphone—Vomiting—Etoposide—lung cancer	0.000179	0.000491	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—lung cancer	0.000179	0.000491	CcSEcCtD
Oxymorphone—Dermatitis—Etoposide—lung cancer	0.000178	0.000487	CcSEcCtD
Oxymorphone—Headache—Etoposide—lung cancer	0.000177	0.000484	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—lung cancer	0.000176	0.000484	CcSEcCtD
Oxymorphone—Chest pain—Methotrexate—lung cancer	0.000176	0.000483	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—lung cancer	0.000176	0.000482	CcSEcCtD
Oxymorphone—Vomiting—Paclitaxel—lung cancer	0.000176	0.000482	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000175	0.000479	CcSEcCtD
Oxymorphone—Dermatitis—Paclitaxel—lung cancer	0.000174	0.000477	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—lung cancer	0.000174	0.000477	CcSEcCtD
Oxymorphone—Headache—Paclitaxel—lung cancer	0.000173	0.000475	CcSEcCtD
Oxymorphone—Hypersensitivity—Docetaxel—lung cancer	0.000173	0.000473	CcSEcCtD
Oxymorphone—Confusional state—Methotrexate—lung cancer	0.00017	0.000467	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—lung cancer	0.000169	0.000463	CcSEcCtD
Oxymorphone—Asthenia—Docetaxel—lung cancer	0.000168	0.000461	CcSEcCtD
Oxymorphone—Nausea—Etoposide—lung cancer	0.000167	0.000459	CcSEcCtD
Oxymorphone—Pruritus—Docetaxel—lung cancer	0.000166	0.000454	CcSEcCtD
Oxymorphone—Nervous system disorder—Methotrexate—lung cancer	0.000166	0.000454	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—lung cancer	0.000165	0.000451	CcSEcCtD
Oxymorphone—Nausea—Paclitaxel—lung cancer	0.000164	0.00045	CcSEcCtD
Oxymorphone—Skin disorder—Methotrexate—lung cancer	0.000164	0.000449	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methotrexate—lung cancer	0.000163	0.000447	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—lung cancer	0.000161	0.000441	CcSEcCtD
Oxymorphone—Anorexia—Methotrexate—lung cancer	0.000161	0.000441	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—lung cancer	0.000161	0.00044	CcSEcCtD
Oxymorphone—Diarrhoea—Docetaxel—lung cancer	0.00016	0.000439	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—lung cancer	0.000158	0.000434	CcSEcCtD
Oxymorphone—Hypotension—Methotrexate—lung cancer	0.000158	0.000432	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—lung cancer	0.000157	0.000431	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—lung cancer	0.000155	0.000425	CcSEcCtD
Oxymorphone—Dizziness—Docetaxel—lung cancer	0.000155	0.000425	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—lung cancer	0.000155	0.000424	CcSEcCtD
Oxymorphone—Insomnia—Methotrexate—lung cancer	0.000153	0.000419	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—lung cancer	0.000152	0.000418	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—lung cancer	0.000152	0.000417	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000151	0.000415	CcSEcCtD
Oxymorphone—Dyspnoea—Methotrexate—lung cancer	0.00015	0.000413	CcSEcCtD
Oxymorphone—Somnolence—Methotrexate—lung cancer	0.00015	0.000411	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—lung cancer	0.000149	0.000409	CcSEcCtD
Oxymorphone—Vomiting—Docetaxel—lung cancer	0.000149	0.000408	CcSEcCtD
Oxymorphone—Dyspepsia—Methotrexate—lung cancer	0.000149	0.000407	CcSEcCtD
Oxymorphone—Dermatitis—Docetaxel—lung cancer	0.000148	0.000404	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—lung cancer	0.000147	0.000404	CcSEcCtD
Oxymorphone—Decreased appetite—Methotrexate—lung cancer	0.000147	0.000402	CcSEcCtD
Oxymorphone—Headache—Docetaxel—lung cancer	0.000147	0.000402	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—lung cancer	0.000146	0.000401	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Methotrexate—lung cancer	0.000146	0.000399	CcSEcCtD
Oxymorphone—Fatigue—Methotrexate—lung cancer	0.000146	0.000399	CcSEcCtD
Oxymorphone—Pain—Methotrexate—lung cancer	0.000144	0.000396	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—lung cancer	0.000144	0.000394	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—lung cancer	0.000143	0.000393	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—lung cancer	0.000143	0.000391	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—lung cancer	0.000142	0.000389	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—lung cancer	0.000141	0.000387	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—lung cancer	0.000139	0.000382	CcSEcCtD
Oxymorphone—Nausea—Docetaxel—lung cancer	0.000139	0.000381	CcSEcCtD
Oxymorphone—Feeling abnormal—Methotrexate—lung cancer	0.000139	0.000381	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methotrexate—lung cancer	0.000138	0.000378	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—lung cancer	0.000137	0.000374	CcSEcCtD
Oxymorphone—Urticaria—Methotrexate—lung cancer	0.000134	0.000368	CcSEcCtD
Oxymorphone—Abdominal pain—Methotrexate—lung cancer	0.000133	0.000366	CcSEcCtD
Oxymorphone—Body temperature increased—Methotrexate—lung cancer	0.000133	0.000366	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—lung cancer	0.000132	0.000362	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—lung cancer	0.00013	0.000357	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—lung cancer	0.00013	0.000356	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—lung cancer	0.000129	0.000353	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—lung cancer	0.000127	0.000348	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000126	0.000346	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—lung cancer	0.000126	0.000345	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—lung cancer	0.000125	0.000343	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—lung cancer	0.000125	0.000343	CcSEcCtD
Oxymorphone—Hypersensitivity—Methotrexate—lung cancer	0.000124	0.000341	CcSEcCtD
Oxymorphone—Asthenia—Methotrexate—lung cancer	0.000121	0.000332	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—lung cancer	0.00012	0.00033	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—lung cancer	0.00012	0.000328	CcSEcCtD
Oxymorphone—Pruritus—Methotrexate—lung cancer	0.000119	0.000327	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—lung cancer	0.000116	0.000318	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—lung cancer	0.000116	0.000317	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—lung cancer	0.000116	0.000317	CcSEcCtD
Oxymorphone—Diarrhoea—Methotrexate—lung cancer	0.000115	0.000317	CcSEcCtD
Oxymorphone—Dizziness—Methotrexate—lung cancer	0.000112	0.000306	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—lung cancer	0.000108	0.000295	CcSEcCtD
Oxymorphone—Vomiting—Methotrexate—lung cancer	0.000107	0.000294	CcSEcCtD
Oxymorphone—Dermatitis—Methotrexate—lung cancer	0.000106	0.000291	CcSEcCtD
Oxymorphone—Headache—Methotrexate—lung cancer	0.000106	0.00029	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—lung cancer	0.000105	0.000287	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—lung cancer	0.000103	0.000283	CcSEcCtD
Oxymorphone—Nausea—Methotrexate—lung cancer	0.0001	0.000275	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—lung cancer	0.0001	0.000274	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—lung cancer	9.66e-05	0.000265	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—lung cancer	9.29e-05	0.000255	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—lung cancer	9.21e-05	0.000252	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—lung cancer	9.16e-05	0.000251	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—lung cancer	8.68e-05	0.000238	CcSEcCtD
Oxymorphone—CYP2D6—Metabolism—GSTA1—lung cancer	2.73e-05	0.000288	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCC3—lung cancer	2.7e-05	0.000285	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AVP—lung cancer	2.68e-05	0.000283	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CB—lung cancer	2.67e-05	0.000282	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL2—lung cancer	2.64e-05	0.000278	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TERT—lung cancer	2.63e-05	0.000277	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AKR1C1—lung cancer	2.61e-05	0.000276	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF1R—lung cancer	2.58e-05	0.000272	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CNDP2—lung cancer	2.58e-05	0.000272	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTM2—lung cancer	2.58e-05	0.000272	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL8—lung cancer	2.57e-05	0.000271	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FGFR1—lung cancer	2.55e-05	0.000269	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—UGT1A1—lung cancer	2.54e-05	0.000268	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HES1—lung cancer	2.54e-05	0.000268	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CG—lung cancer	2.53e-05	0.000267	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APC—lung cancer	2.53e-05	0.000267	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KIT—lung cancer	2.53e-05	0.000267	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—NRAS—lung cancer	2.53e-05	0.000266	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HIF1A—lung cancer	2.52e-05	0.000265	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTMR3—lung cancer	2.51e-05	0.000264	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGF—lung cancer	2.5e-05	0.000263	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—RAF1—lung cancer	2.49e-05	0.000262	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—IL2—lung cancer	2.46e-05	0.000259	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GNG11—lung cancer	2.45e-05	0.000258	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PGAM1—lung cancer	2.44e-05	0.000257	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CB—lung cancer	2.43e-05	0.000256	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APOA1—lung cancer	2.43e-05	0.000256	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—MAPK3—lung cancer	2.42e-05	0.000255	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—POMC—lung cancer	2.41e-05	0.000254	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KDR—lung cancer	2.41e-05	0.000254	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—BRAF—lung cancer	2.38e-05	0.000251	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6R—lung cancer	2.35e-05	0.000247	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CREBBP—lung cancer	2.34e-05	0.000247	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL8—lung cancer	2.33e-05	0.000246	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALDOA—lung cancer	2.33e-05	0.000246	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP2A7—lung cancer	2.33e-05	0.000246	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ERBB3—lung cancer	2.32e-05	0.000245	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—EGFR—lung cancer	2.3e-05	0.000243	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SDC4—lung cancer	2.28e-05	0.00024	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NCOA3—lung cancer	2.26e-05	0.000239	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAP2K1—lung cancer	2.24e-05	0.000236	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL2—lung cancer	2.23e-05	0.000235	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TERT—lung cancer	2.22e-05	0.000234	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CD—lung cancer	2.22e-05	0.000234	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APC—lung cancer	2.22e-05	0.000234	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CG—lung cancer	2.22e-05	0.000234	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KIT—lung cancer	2.22e-05	0.000234	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—NRAS—lung cancer	2.22e-05	0.000234	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ADCY1—lung cancer	2.2e-05	0.000232	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCG2—lung cancer	2.2e-05	0.000232	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CA—lung cancer	2.2e-05	0.000232	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGF—lung cancer	2.19e-05	0.000231	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—KRAS—lung cancer	2.17e-05	0.000229	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ENO2—lung cancer	2.16e-05	0.000228	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—HPGDS—lung cancer	2.16e-05	0.000228	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FGFR1—lung cancer	2.16e-05	0.000228	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.14e-05	0.000226	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HIF1A—lung cancer	2.13e-05	0.000224	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—MAPK3—lung cancer	2.12e-05	0.000224	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—POMC—lung cancer	2.11e-05	0.000222	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTT1—lung cancer	2.09e-05	0.000221	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—BRAF—lung cancer	2.08e-05	0.00022	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—RRM1—lung cancer	2.08e-05	0.000219	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA3—lung cancer	2.08e-05	0.000219	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP2A6—lung cancer	2.07e-05	0.000218	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GCLC—lung cancer	2.07e-05	0.000218	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6R—lung cancer	2.06e-05	0.000217	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CREBBP—lung cancer	2.05e-05	0.000217	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APOA1—lung cancer	2.05e-05	0.000216	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KDR—lung cancer	2.03e-05	0.000214	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—EGFR—lung cancer	2.02e-05	0.000213	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CA—lung cancer	2e-05	0.000211	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MDM2—lung cancer	1.99e-05	0.00021	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RAF1—lung cancer	1.98e-05	0.000209	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ERBB2—lung cancer	1.96e-05	0.000207	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ENO1—lung cancer	1.96e-05	0.000207	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAP2K1—lung cancer	1.96e-05	0.000207	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—B4GALT5—lung cancer	1.95e-05	0.000206	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CD—lung cancer	1.95e-05	0.000205	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MTOR—lung cancer	1.94e-05	0.000204	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CB—lung cancer	1.94e-05	0.000204	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	1.93e-05	0.000203	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—KRAS—lung cancer	1.91e-05	0.000201	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA4—lung cancer	1.9e-05	0.0002	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KIT—lung cancer	1.87e-05	0.000198	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CG—lung cancer	1.87e-05	0.000198	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APC—lung cancer	1.87e-05	0.000198	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—NRAS—lung cancer	1.87e-05	0.000197	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL8—lung cancer	1.86e-05	0.000196	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGF—lung cancer	1.85e-05	0.000195	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA2—lung cancer	1.85e-05	0.000195	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HRAS—lung cancer	1.85e-05	0.000195	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AKT1—lung cancer	1.8e-05	0.00019	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—MAPK3—lung cancer	1.79e-05	0.000189	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTA1—lung cancer	1.79e-05	0.000188	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—POMC—lung cancer	1.78e-05	0.000188	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CASP3—lung cancer	1.78e-05	0.000188	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL2—lung cancer	1.78e-05	0.000188	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—lung cancer	1.77e-05	0.000187	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCC3—lung cancer	1.77e-05	0.000186	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—BRAF—lung cancer	1.76e-05	0.000186	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP2E1—lung cancer	1.76e-05	0.000186	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	1.75e-05	0.000185	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MDM2—lung cancer	1.75e-05	0.000184	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—NQO1—lung cancer	1.74e-05	0.000183	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RAF1—lung cancer	1.74e-05	0.000183	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6R—lung cancer	1.74e-05	0.000183	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CREBBP—lung cancer	1.74e-05	0.000183	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCND1—lung cancer	1.73e-05	0.000183	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—JUN—lung cancer	1.73e-05	0.000182	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ERBB2—lung cancer	1.72e-05	0.000181	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AKR1C1—lung cancer	1.71e-05	0.00018	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—EGFR—lung cancer	1.71e-05	0.00018	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MTOR—lung cancer	1.7e-05	0.000179	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CB—lung cancer	1.7e-05	0.000179	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MMP9—lung cancer	1.68e-05	0.000177	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CDKN1A—lung cancer	1.68e-05	0.000177	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTEN—lung cancer	1.67e-05	0.000176	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—UGT1A1—lung cancer	1.66e-05	0.000175	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAP2K1—lung cancer	1.66e-05	0.000175	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CD—lung cancer	1.65e-05	0.000174	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AKT1—lung cancer	1.63e-05	0.000172	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL8—lung cancer	1.63e-05	0.000172	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.63e-05	0.000172	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HRAS—lung cancer	1.62e-05	0.000171	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—KRAS—lung cancer	1.61e-05	0.00017	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GNG11—lung cancer	1.6e-05	0.000169	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EP300—lung cancer	1.6e-05	0.000168	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AKT1—lung cancer	1.58e-05	0.000166	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—STK11—lung cancer	1.57e-05	0.000165	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CASP3—lung cancer	1.56e-05	0.000165	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL2—lung cancer	1.56e-05	0.000164	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—SRC—lung cancer	1.55e-05	0.000164	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—lung cancer	1.55e-05	0.000164	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALDOA—lung cancer	1.52e-05	0.000161	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCND1—lung cancer	1.52e-05	0.00016	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—JUN—lung cancer	1.52e-05	0.00016	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—VEGFA—lung cancer	1.51e-05	0.000159	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STAT3—lung cancer	1.5e-05	0.000158	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NRAS—lung cancer	1.49e-05	0.000157	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	1.48e-05	0.000156	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NCOA3—lung cancer	1.48e-05	0.000156	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MMP9—lung cancer	1.48e-05	0.000156	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MDM2—lung cancer	1.47e-05	0.000156	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CDKN1A—lung cancer	1.47e-05	0.000155	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RAF1—lung cancer	1.47e-05	0.000155	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTEN—lung cancer	1.47e-05	0.000155	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ERBB2—lung cancer	1.45e-05	0.000153	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTP1—lung cancer	1.45e-05	0.000153	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ADCY1—lung cancer	1.44e-05	0.000152	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCG2—lung cancer	1.44e-05	0.000152	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MTOR—lung cancer	1.43e-05	0.000151	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CB—lung cancer	1.43e-05	0.000151	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AKT1—lung cancer	1.43e-05	0.000151	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK3—lung cancer	1.43e-05	0.000151	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CAT—lung cancer	1.41e-05	0.000149	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HPGDS—lung cancer	1.41e-05	0.000149	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ENO2—lung cancer	1.41e-05	0.000149	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.4e-05	0.000148	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EP300—lung cancer	1.4e-05	0.000148	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MYC—lung cancer	1.39e-05	0.000147	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL8—lung cancer	1.38e-05	0.000145	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCB1—lung cancer	1.37e-05	0.000145	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HRAS—lung cancer	1.37e-05	0.000144	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTT1—lung cancer	1.37e-05	0.000144	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SRC—lung cancer	1.36e-05	0.000143	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGFR—lung cancer	1.36e-05	0.000143	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GCLC—lung cancer	1.35e-05	0.000143	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP2A6—lung cancer	1.35e-05	0.000143	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—TYMS—lung cancer	1.35e-05	0.000142	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GSTM1—lung cancer	1.33e-05	0.000141	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AKT1—lung cancer	1.33e-05	0.00014	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—VEGFA—lung cancer	1.33e-05	0.00014	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CASP3—lung cancer	1.32e-05	0.000139	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL2—lung cancer	1.32e-05	0.000139	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STAT3—lung cancer	1.31e-05	0.000138	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—lung cancer	1.31e-05	0.000138	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NRAS—lung cancer	1.31e-05	0.000138	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KRAS—lung cancer	1.28e-05	0.000135	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCND1—lung cancer	1.28e-05	0.000135	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ENO1—lung cancer	1.28e-05	0.000135	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—JUN—lung cancer	1.28e-05	0.000135	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP1A1—lung cancer	1.26e-05	0.000133	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ERCC2—lung cancer	1.25e-05	0.000132	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK3—lung cancer	1.25e-05	0.000132	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP9—lung cancer	1.25e-05	0.000132	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN1A—lung cancer	1.24e-05	0.000131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTEN—lung cancer	1.24e-05	0.000131	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MYC—lung cancer	1.22e-05	0.000129	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKT1—lung cancer	1.21e-05	0.000128	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGFR—lung cancer	1.19e-05	0.000126	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EP300—lung cancer	1.18e-05	0.000125	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	0.000124	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP2E1—lung cancer	1.15e-05	0.000121	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SRC—lung cancer	1.15e-05	0.000121	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TP53—lung cancer	1.14e-05	0.00012	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—NQO1—lung cancer	1.14e-05	0.00012	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KRAS—lung cancer	1.13e-05	0.000119	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VEGFA—lung cancer	1.12e-05	0.000118	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STAT3—lung cancer	1.11e-05	0.000117	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NRAS—lung cancer	1.11e-05	0.000117	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HRAS—lung cancer	1.09e-05	0.000115	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—APOA1—lung cancer	1.08e-05	0.000114	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK3—lung cancer	1.06e-05	0.000112	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—lung cancer	1.05e-05	0.00011	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CA—lung cancer	1.03e-05	0.000109	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MYC—lung cancer	1.03e-05	0.000109	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—STK11—lung cancer	1.03e-05	0.000108	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGFR—lung cancer	1.01e-05	0.000106	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TP53—lung cancer	1e-05	0.000106	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CG—lung cancer	9.9e-06	0.000104	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKT1—lung cancer	9.64e-06	0.000102	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HRAS—lung cancer	9.58e-06	0.000101	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KRAS—lung cancer	9.52e-06	0.0001	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTP1—lung cancer	9.49e-06	0.0001	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—POMC—lung cancer	9.42e-06	9.94e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CAT—lung cancer	9.23e-06	9.74e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CREBBP—lung cancer	9.18e-06	9.68e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—lung cancer	9.16e-06	9.67e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCB1—lung cancer	8.98e-06	9.47e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—TYMS—lung cancer	8.82e-06	9.3e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CA—lung cancer	8.75e-06	9.23e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GSTM1—lung cancer	8.72e-06	9.19e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CD—lung cancer	8.7e-06	9.18e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALB—lung cancer	8.59e-06	9.06e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TP53—lung cancer	8.46e-06	8.92e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT1—lung cancer	8.46e-06	8.92e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP1A1—lung cancer	8.26e-06	8.72e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ERCC2—lung cancer	8.2e-06	8.64e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HRAS—lung cancer	8.09e-06	8.54e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—lung cancer	7.75e-06	8.17e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CB—lung cancer	7.59e-06	8e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS2—lung cancer	7.52e-06	7.93e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT1—lung cancer	7.15e-06	7.54e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—APOA1—lung cancer	7.09e-06	7.48e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTEN—lung cancer	6.56e-06	6.91e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CG—lung cancer	6.47e-06	6.83e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—EP300—lung cancer	6.25e-06	6.59e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—POMC—lung cancer	6.16e-06	6.5e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CREBBP—lung cancer	6e-06	6.33e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CD—lung cancer	5.69e-06	6e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALB—lung cancer	5.62e-06	5.92e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CB—lung cancer	4.96e-06	5.23e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS2—lung cancer	4.91e-06	5.18e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CA—lung cancer	4.62e-06	4.88e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTEN—lung cancer	4.29e-06	4.52e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—EP300—lung cancer	4.09e-06	4.31e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AKT1—lung cancer	3.78e-06	3.98e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CA—lung cancer	3.02e-06	3.19e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AKT1—lung cancer	2.47e-06	2.61e-05	CbGpPWpGaD
